Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties

Biological Chemistry

Volumn 384, Issue 3, 2003, Pages 423-435

  Al Fahkri, Nadia ^a   Chavakis, Triantafyllos ^a   Schmidt Wöll, Thomas ^a   Huang, Bei ^a   Cherian, Sanjay M ^b   Bobryshev, Yuri V ^b   Lord, Reginald S A ^b   Katz, Norbert ^a   Preissner, Klaus T ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apoptosis; Endothelial cells; Integrins; Plasmin activation system; Vascular smooth muscle cells; Vitronectin

Indexed keywords

ALPHA5 INTEGRIN; ANNEXIN; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DNA FRAGMENT; FIBRONECTIN; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; HYPOCHOLESTEROLEMIC AGENT; INSULIN; NITRIC ACID DERIVATIVE; PHENPROCOUMON; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN INHIBITOR; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ADULT; AGED; APOPTOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; ARTERIOSCLEROSIS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HUMANS; KININOGENS; MOLECULAR WEIGHT; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; VITRONECTIN;

EID: 0038405134     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.048     Document Type: Review

References (55)

1. Aderem, A., and Underhill, D.M. (1999). Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593-623.
2. Asakura, S., Hurley, R.W., Skorstengaard, K., Ohkubo, I., and Mosher, D.F. (1992). Inhibition of cell adhesion by high molecular weight kininogen. J. Cell. Biol. 116, 465-476.
3. Ayad, S., Boot-Handford, R.P., Humphries, M.J., Kadler, K.E., and Shuttleworth, C.A. (1994). The extracellular matrix facts book (London, San Diego: Academic Press), pp. 13-14, 149-151.
4. Barnathan, E.S. (1992). Characterization and regulation of the urokinase receptor of human endothelial cells. Fibrinolysis 6 (Suppl. 1), 1-9.
5. Bobryshev, Y.V., Babaev, V.R., Lord, R.S., and Watanabe, T. (1997). Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis. In vivo 11, 441-452.
6. Buckley, C.D., Pilling, D., Henriquez, N.V., Parsonage, G., Threlfall, K., Scheel-Troellner, D., Simmons, D.L., Akbar, A.N., Lord, J.M., and Salmon, M. (1999). RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397, 534-539.
7. Cai, W., Devaux, B., Schaper, W., and Schaper, J. (1997). The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131, 177-186.
8. Carmeliet, P., and Collen, D. (1997). Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis. Curr. Opin. Lipidol. 8, 188-225.
9. Chavakis, T., Kanse, S.M., Yutzy, B., Lijnen, H.R., and Preissner, K.T. (1998). Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Blood 91, 2305-2312.
10. Chavakis, T., Kanse, S.M., Lupu, F., Hammes, H.P., Müller-Esterl, W., Pixley, R.A., Colman, R.W., and Preissner, K.T. (2000). Different mechanisms define the anti-adhesive function of high molecular weight kininogen in integrin- and urokinase-dependent interactions. Blood 96, 514-522.
11. Chavakis, T., Willuweit, A.K., Lupu, F., Preissner, K.T., and Kanse, S.M. (2001). Release of soluble urokinase receptor from vascular cells. Thromb. Haemost. 86, 686-93.
12. Christ, G., Kostner, K., Zehetgruber, M., Binder, B.R., Gulba, D., and Huber, K. (1999). Plasmin activation system in restenosis: Role in pathogenesis and clinical prediction? J. Thromb. Thrombol. 7, 277-285.
13. Colman, R.W., and Schmaier, A.H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
14. Colman, R.W., Pixley, R.A., Najamunnisa, S., Yan, W.Y, Wang, J.Y., Mazar, A., and McCrae, K.R. (1997). Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100, 1481-1486.
15. Colman, R.W., Jameson, B.A., Lin, Y., Johnson, D., and Mousa, S.A. (2000). Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 95, 543-550.
16. Cugno, M., Scott, C.F., Salerno, F., Lorenzano, E., Muller-Esterl, W., Agostoni, A., and Colman R.W. (1999). Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis. Thromb. Haemost. 82, 1428-1432.
17. Declerck, P.J., and Collen, D. (1990). Measurement of plasminogen activator inhibitor type 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb. Res. Suppl. 10, 3-9.
18. Declerck, P.J., van Keer, L., Verstreken, M., and Collen, D. (1992). An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of uPA. Thromb. Haemost, 67, 95-100.
19. Didenko, V.V., and Hornsby, P.J. (1996). Presence of double-strand breaks with single-base 3′overhangs in cells undergoing apoptosis but not necrosis. J. Cell. Biol. 135, 1369-1376.
20. El-Dahr, S.S. (1998). The kininogen gene family in obstructive uropathy. Semin. Nephrol. 18, 633-640.
21. Fukai, F., Mashimo, M., Akiyama, K., Goto, T., Tanuma, S., and Katayama, T. (1998). Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp. Cell. Res. 242, 92-99.
22. Geng, Y.J., Henderson, L.E., Levesque, E.B., Muszynski, M., and Libby, P. (1997). Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primied human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 2200-2208.
23. Germer, M., Kanse, S.M., Kirkegaard, T., Kjoller, L., Felding-Habermann, B., Goodman, S., and Preissner, K.T. (1998). Kinetic analysis of integrin-dependent cell adhesion on vitronectin. The inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides. Eur. J. Biochem. 253, 669-674.
24. Isik, F.F., Gibran, N.S., Jang, Y.C., Sandell, L., and Schwartz, S.M. (1998). Vitronectin decreases endothelial cell apoptosis. J. Cell. Physiol. 175, 149-155.
25. Isner, J.M., Kearney, M., Bortman, S., and Paseri, J. (1995). Apoptosis in human atherosclerosis and restenosis. Circulation 91, 2703-2711.
26. Kanoh, M., Takemura, G., Misao, J., Hayakawa, Y., Aoyama, T., Nishigaki, K., Noda, T., Fujiwara, T., Fukuda, K., Minatoguchi, S., and Fujiwara, H. (1999). Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Ciculation 99, 2757-2764.
27. Kaufmann, J., Haasemann, M., Modrow, S., and Müller-Esterl, W. (1993). Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties. J. Biol. Chem. 268, 9079-9091.
28. Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
29. Kwaan, H.C., Wang, J., Svoboda, K., and Declerck, P.J. (2000). Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br. J. Cancer 82, 1702-1708.
30. Lupu, F., Bergonzelli, G.E., Heim, D.A., Cousin, E., Genton, C.Y., Bachmann, F., and Kruithof, E.K. (1993). Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler. Thromb. Vasc. Biol. 13, 1090-1100.
31. Martin, S.J., Reutelingsperger, C.P.M., McGahon, A.J., Rader, J., Van Schie, R.C.A.A., LaFace, D.M., and Green, D.R. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus. Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545-1557.
32. Matsuno, H., Stassen, J.M., Vermylen, J., and Deckmyn, H. (1994). Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90, 2203-2206.
33. McCaffrey, T.A. (2000). TGF-β and TGF-β receptors in atherosclerosis. Cytokine Growth Factor Rev. 11, 103-114.
34. Myohanen, H.T., Stephens, R.W., Hedman, K., Tapiovaara, H., Ronne, E., Hoyer-Hansen, G., Dano, K., and Vaheri, A. (1993). Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem. 41, 1291-1301.
35. O'Mullane, M.J., and Baker, M.S. (1999). Elevated plasminogen receptor expression occurs as a degradative phase event in cellular apoptosis. Immunol. Cell. Biol. 77, 249-255.
36. Owens, G.K., and Thompson, M.M. (1986). Development changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J. Biol. Chem. 261, 13373-13380.
37. Padro, T., Steins, M., Li, C.X., Mesters, R.M., Hammel, D., Scheld, H.H., and Kienast, J. (1997). Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc. Res. 36, 28-36.
38. Porter, A.G., and Janicke, R.U. (1999). Emerging role of caspase-3 in apoptosis. Cell. Death Differ. 6, 99-104.
39. Preissner, K.T., May, A.E., Wohn, K.D., Germer, M., and Kanse, S.M. (1997). Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb. Haemost. 78, 88-95.
40. Preissner, K.T., Kanse, S.M., Chavakis, T., and May, A.E. (1999). The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function. Basic Res. Cardiol. 94, 315-321.
41. Preissner, K.T., Kanse, S.M., and May, A.E. (2000). Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628.
42. Raghunath, P.N., Tomaszewski, J.E., Brady, S.T, Caron, R.J., Okada, S.S., and Barnathan, E.S. (1995). Plasminogen activator system in human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1432-1443.
43. Robbie, L.A., Booth, N.A., Brown, P.A.J., and Bennett, B. (1996). Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 16, 539-545.
44. Schneiderman, J., Sawdey, M.S., Keeton, M.R., Bordin, G.M., Bernstein, E.F., Dilley, R.B., and Loskutoff, D.J. (1992). Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 89, 6998-7002.
45. Simonitsch, I., and Krupitza, G. (1998). Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor α (TNF-α). Br. J. Cancer 78, 862-870.
46. Stary, H.C. (1992). Composition and classification of human atherosclerotic lesions. Virchows Arch. A Pathol. Anat. Histopathol. 421, 277-290.
47. Stefansson, S., and Lawrence, D.A. (1996). The serpine PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Nature 383, 441-443.
48. Stockmann, A., Hess, S., Declerck, P., Timpl, R., and Preissner, K.T. (1993). Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J. Biol. Chem. 268, 22874-22882.
49. Sueyoshi, T., Enjyoji, K., Shimada, T., Kato, H., Iwanaga, S., Bando, Y., Kominami, E., and Katunuma, N. (1985). A new function of kininogens as thiol-proteinase inhibitors: Inhibition of papain and cathepsin B, H and L by bovine, rat and human plasma kininogens. FEBS Lett. 182, 193-195.
50. Van Aken, B.E., Seiffert, D., Thinnes, T., and Loskutoff, D.J. (1997). Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem. Cell Biol. 107, 313-320.
51. Vassalli, J.D. (1994). The urokinase receptor. Fibrinolysis 8 (Suppl. I), 172-181.
52. Waltz, D.A., Natkin, L.R., Fujita, R.M., Wei, Y., and Chapman, H.A. (1997). Plasmin and plasminogen activator inhibitor type I promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100, 58-65.
53. Wei, Y., Waltz, D.A., Rao, N., Drummond, R.J., Rosenberg, S., and Chapman, H.A. (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269, 32380-32385.
54. Wertz, I.E., and Hanley, M.R. (1996). Diverse molecular provocation of programmed cell death. Trends Biochem. Sci. 21, 359-364.
55. Zhang, J.C., Claffey, K., Sakthivel, R., Darzynkiewicz, Z., Shaw, D.E., Leal, J., Wang, Y.C., Lu, F.M., and McCrae, K.R. (2000). Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 14, 2589-2600.